$4.62
0.091.99%
Last update: 4:21 PM
15 minutes delayed
Comments
Loading...
TELA Bio
TELANASDAQ
Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
TELA Bio (NASDAQ:TELA) Stock, Analyst Ratings, Price Targets, Forecasts
TELA Bio Inc has a consensus price target of $13.5 based on the ratings of 4 analysts. The high is $15 issued by JMP Securities on March 22, 2024. The low is $10 issued by Piper Sandler on May 10, 2024. The 3 most-recent analyst ratings were released by Piper Sandler, JMP Securities, and Piper Sandler on May 10, 2024, March 22, 2024, and March 22, 2024, respectively. With an average price target of $12.33 between Piper Sandler, JMP Securities, and Piper Sandler, there's an implied 165.23% upside for TELA Bio Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Piper Sandler
JMP Securities
Lake Street
Canaccord Genuity
1calculated from analyst ratings
Analyst Ratings for TELA Bio
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/10/2024 | Buy Now | 115.05% | Piper Sandler | Matt O'Brien | $12 → $10 | Reiterates | Overweight → Overweight | Get Alert |
| 03/22/2024 | Buy Now | 222.58% | JMP Securities | David Turkaly | → $15 | Reiterates | Market Outperform → Market Outperform | Get Alert |
| 03/22/2024 | Buy Now | 158.06% | Piper Sandler | Matt O'Brien | $15 → $12 | Maintains | Overweight | Get Alert |
| 12/27/2023 | Buy Now | 201.08% | Lake Street | Frank Takkinen | $14 → $14 | Reiterates | Buy → Buy | Get Alert |
| 11/10/2023 | Buy Now | 222.58% | JMP Securities | David Turkaly | $20 → $15 | Maintains | Market Outperform | Get Alert |
| 03/28/2023 | Buy Now | 222.58% | Canaccord Genuity | Kyle Rose | → $15 | Reiterates | → Buy | Get Alert |
| 03/22/2023 | Buy Now | 330.11% | JMP Securities | David Turkaly | → $20 | Reiterates | → Market Outperform | Get Alert |
| 11/10/2022 | Buy Now | 330.11% | JMP Securities | David Turkaly | $22 → $20 | Maintains | Market Outperform | Get Alert |
| 11/10/2022 | Buy Now | 222.58% | Piper Sandler | Matt O'Brien | $20 → $15 | Maintains | Overweight | Get Alert |
FAQ
What is the target price for TELA Bio (TELA) stock?
The latest price target for TELA Bio (NASDAQ:TELA) was reported by Piper Sandler on May 10, 2024. The analyst firm set a price target for $10.00 expecting TELA to rise to within 12 months (a possible 116.45% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for TELA Bio (TELA)?
The latest analyst rating for TELA Bio (NASDAQ:TELA) was provided by Piper Sandler, and TELA Bio reiterated their overweight rating.
When was the last upgrade for TELA Bio (TELA)?
There is no last upgrade for TELA Bio
When was the last downgrade for TELA Bio (TELA)?
There is no last downgrade for TELA Bio.
When is the next analyst rating going to be posted or updated for TELA Bio (TELA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of TELA Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for TELA Bio was filed on May 10, 2024 so you should expect the next rating to be made available sometime around May 10, 2025.
Is the Analyst Rating TELA Bio (TELA) correct?
While ratings are subjective and will change, the latest TELA Bio (TELA) rating was a reiterated with a price target of $12.00 to $10.00. The current price TELA Bio (TELA) is trading at is $4.62, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.